Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
, Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial, Lancet Diabetes Endocrinol
The consistency of these improvements across study visits suggested sustained metabolic benefit rather than temporary fluctuations
The pills must also be taken on an empty stomach to work effectively
However, results depend on consistency, dosage, and lifestyle habits
US$ 21.81
US$ 22.37
US$ 29.12
US$ 24.85
US$ 25.89
:max_bytes(150000):strip_icc()/Health-GettyImages-2200929852-cbe13f76512c4cd3b51252536927920f.jpg)
US$ 28.83
